Anhydrous Topical Composition for Scar Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for reducing scar tissue are ineffective, as they often fail to address the collagen network reforming after a wound, leading to unsatisfactory results in reducing the appearance of scars.

Innovation Solution

A topical composition comprising MCT, monolaurin, cetyl esters, marine oil, vegetable oils with high omega-3 fatty acid content, and rice bran wax, which is applied topically to reduce the appearance of scar tissue and promote wound healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional topical treatments are applied to reduce scar tissue, then the appearance of scars may be slightly improved, but the treatments fail to effectively address the collagen network reforming process

Engineering Contradiction:
Improveeffectiveness in reducing scar appearanceVSAvoidaddressing collagen network reforming
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent changes the chemical parameters of the topical composition by incorporating specific enzymes (collagenase, elastase, proteases) and fatty acid profiles (omega-3, omega-6, omega-9) to effectively address collagen network reforming. This transforms conventional treatments from non-specific to targeted biochemical action, resolving the contradiction between general scar appearance improvement and specific collagen network addressing.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite topical formulation combining multiple active ingredients including enzymes, fatty acids, and carrier oils. This composite approach enables simultaneous action on collagen degradation, skin hydration, and barrier function, achieving both scar appearance reduction and collagen network addressing that conventional single-ingredient treatments cannot accomplish.

Inventive Principle:
Principle #40Composite materials

2Reliability

If the topical composition is made with specific active ingredients to address collagen network, then effectiveness in reducing scarring improves, but the formulation complexity increases

Engineering Contradiction:
Improvescarring reduction effectivenessVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs multi-functional ingredients that perform multiple roles: carrier oils provide both hydration and solubility for active ingredients; fatty acid profiles simultaneously support skin barrier function and modulate inflammation; enzymes address collagen network while being delivered through the same topical application system. This multi-functionality reduces the need for separate formulation components, managing complexity while maintaining effectiveness.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of manufacture

If conventional treatments are used, then the formulation remains simple, but they fail to provide satisfactory results in reducing scar appearance

Engineering Contradiction:
Improveformulation simplicityVSAvoidscar appearance reduction
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent uses carrier oils and fatty acid esters as intermediaries to deliver active enzymatic ingredients to the target collagen network. These intermediaries facilitate the interaction between simple topical application and complex biochemical action, maintaining ease of manufacture while achieving reliable scar reduction through effective ingredient delivery and activation at the skin level.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20250041259A1Topical compositions for reducing scarring
Publication Date: 2025.02.06 OMEZA HOLDINGS INC
  • US20250041259A1 patent drawing
  • US20250041259A1 patent drawing
  • US20250041259A1 patent drawing

AI summary

The present disclosure pertains to an anhydrous topical composition for retarding and/or inhibiting scarring of a wound, burn and/or skin condition located on the skin of a subject. Additionally, the topical composition may comprise the following: MCT, monolaurin, cetyl esters, marine oil, vegetable oil having an omega 3 fatty acid content greater than 9 wt %, and/or rice bran wax.